Electrocardiogram guided leadless pacemaker implantation

By employing cardiac signal information to guide leadless pacemaker placement, the challenges of inaccurate positioning are addressed, improving placement accuracy and reducing cardiomyopathy risk while enhancing procedural efficiency.

WO2026234493A1PCT designated stage Publication Date: 2026-11-12MEDTRONIC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2026/054124
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-08
Filing Date
2026-04-27
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Accurate placement of leadless pacemakers remains challenging due to difficulties in identifying the exact location using fluoroscopic imaging alone, which can lead to improper placement and increased risk of pacing-induced cardiomyopathy.

Method used

Utilizing cardiac signal information, such as ECG and cardiac EGM, in conjunction with or alternative to fluoroscopic imaging, to guide the precise positioning of leadless pacemakers, adjusting or releasing the device based on features like R-wave notch, PDI, QRS duration, and morphological features.

Benefits of technology

Improves the accuracy of leadless pacemaker placement, reducing the risk of pacing-induced cardiomyopathy and enhancing clinician efficiency during implantation procedures.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IB2026054124_12112026_PF_FP_ABST
    Figure IB2026054124_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A system comprising: an implantable medical device (IMD) configured to deliver cardiac pacing pulses to a heart; sensing circuitry configured to sense a cardiac signal; processing circuitry configured to: control a pulse generator to generate a pacing pulse when the IMD is at a first position in the heart; control the sensing circuity to sense a first cardiac signal in response to delivery of the pacing pulse; determine one or more features of the cardiac signal comprising at least an R-wave notch feature; and based on one or more of the one or more features meeting one or more corresponding criteria, output for display an indication to adjust a position of the IMD from the first position to a second position.
Need to check novelty before this filing date? Find Prior Art

Description

Atty Ref. No. A0013175W001ELECTROCARDIOGRAM GUIDED LEADLESS PACEMAKER IMPLANTATION

[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 802,098, filed May 8, 2025, the entire content of which is incorporated herein by reference.FIELD

[0002] This disclosure generally relates to medical devices and, more particularly, to implanting medical devices.BACKGROUND

[0003] Various types of implantable medical devices (IMDs) have been implanted for treating or monitoring one or more conditions of a patient. Such IMDs may be adapted to monitor or treat conditions relating to heart, muscle, nerve, brain, stomach, endocrine organs, or other organs and their related functions. Such IMDs may be associated with leads that position electrodes at a desired location or may be leadless with electrodes integrated with and / or attached to the device housing. These IMDs may have the ability to wirelessly transmit data either to another device implanted in the patient or to another instrument located externally of the patient, or both.

[0004] A cardiac pacemaker is a medical device, e.g., an IMD, configured to deliver cardiac pacing therapy to restore a more normal heart rhythm. Cardiac pacemakers sense the electrical activity of the heart, and deliver cardiac pacing based on the sensed electrical activity, via electrodes. Some cardiac pacemakers are implanted a distance from the heart, and couple to one or more leads that intravascularly extend into the heart to position electrodes with respect to cardiac tissue. Some cardiac pacemakers are sized to be completely implanted within one of the chambers of the heart and may include electrodes integrated with or attached to the device housing rather than leads. Some cardiac pacemakers provide dual chamber functionality, by sensing and / or stimulating the activity of both atria and ventricles, or other multi-chamber functionality. A cardiac pacemaker may provide multi -chamber functionality via leads that extend to respective heart chambers, multiple cardiac pacemakers may provide multi -chamber functionality by being implanted in respective chambers, or a cardiac pacemaker implanted in one chamber may sense and pace multiple chambers.Atty Ref. No. A0013175W001SUMMARY

[0005] In general, this disclosure describes techniques for implanting an implantable medical device (IMD), e.g., a leadless pacemaker, using cardiac signal information, such as one or more of cardiac electrogram (EGM) information or electrocardiogram (ECG) information or information based on other signals produced by the heart in response to pacing pulses. In some examples, the IMD may be an entire IMD or a component thereof. The IMD may be configured to deliver cardiac pacing pulses to a heart of a patient. A system including the IMD may sense the cardiac signal, e.g., one or more of the cardiac EGM, the ECG, or the other signal(s) produced by the heart of the patient in response to pacing pulses. In some examples, the system may additionally or alternatively measure an impedance. In some examples, the system may sense the cardiac signal in response to delivery of a pacing pulse from the system to the heart of the patient. The system may deliver the pacing pulse when the IMD is at a first position within the heart of the patient. The system determines one or more features of the one or more of the ECG, the cardiac EGM, or the other signal (s) produced by the heart of the patient in response to pacing pulses resulting from delivery of the pacing pulse when the IMD is at the first position. In some examples, the one or more features include one or more of an R-wave notch feature, a peak deflection index (PDI) feature, or a QRS duration feature, a morphological feature, a left ventricular activation time feature, or a pacing impedance feature. Based on one or more of the one or more features meeting one or more corresponding criteria, the system outputs an indication to adjust a position of the IMD from the first position to a second position. Based on the one or more features not meeting one or more corresponding criteria, the system may output an indication to release the IMD at the first position.

[0006] In some examples, the IMD may be configured for fixation to patient tissue. For example, the IMD may include fixation elements, such as tines or a helical projection for fixating the IMD to patient tissue. In examples in which the IMD comprises a leadless pacemaker, fixating the IMD to patient tissue may comprise fixing the IMD to a target location within the heart, such as the right ventricular (RV) septum. In some examples, the one or more features may not meet the one or more criteria when the position of the IMD is at the target location, e.g., the RV septum. The one or more features may meet the one or more criteria when the position of the IMD is not at the target location, e.g., when the position of the IMD is at an RV free wall of the heart of the patient. In some examples, theAtty Ref. No. A0013175W001system may determine whether the first position is at the target location before determining to release the IMD at the first position or adjust a position of the IMD from the first position to a second position.

[0007] Many procedures involve using fluoroscopic imaging during implantation of IMDs, e.g., leadless pacemakers. However, accurate placement of leadless pacemakers remains challenging. An exact location of the IMD can be difficult for clinicians to identify based on fluoroscopic imaging alone. By using ECG and / or cardiac EGM information in addition to or alternative to fluoroscopic imaging, the techniques of this disclosure may improve an accuracy of leadless pacemaker placement, which may improve patient outcomes. As an example, when a leadless pacemaker is placed at the RV free wall instead of the RV septum, a patient may be more likely to experience pacing-induced cardiomyopathy than when the leadless pacemaker is placed at the RV septum. Therefore, when the leadless pacemaker is placed at the RV septum, the patient may be less likely to experience pacing-induced cardiomyopathy.

[0008] In addition to improving patient outcomes, the techniques of this disclosure may improve clinician experience. For example, by outputting indications of the position of the IMD and / or indications to adjust the position of the IMD, the techniques of this disclosure may improve an efficiency of the clinician in placing the IMD, which may save the clinician time. In some examples, increasing the efficiency of implantation of the IMD may additionally improve patient experience.

[0009] In one example, a system comprises: an implantable medical device (IMD) configured to deliver cardiac pacing pulses to a heart of a patient; sensing circuitry configured to sense a cardiac signal; processing circuitry configured to: control a pulse generator to generate a pacing pulse when the IMD is at a first position in the heart of the patient; control the sensing circuity to sense a first cardiac signal in response to delivery of the pacing pulse; determine one or more features of the first cardiac signal comprising at least an R-wave notch feature; and based on one or more of the one or more features meeting one or more corresponding criteria, output for display to a user an indication to adjust a position of the IMD from the first position to a second position.

[0010] In another example, a method comprises: controlling, by processing circuitry of a medical device system, a pulse generator of the system to generate a pacing pulse when an implantable medical device (IMD) of the system is at a first position in the heart of theAtty Ref. No. A0013175W001patient; controlling, by the processing circuitry, sensing circuity of the system to sense a cardiac signal in response to delivery of the pacing pulse; determining, by the processing circuitry, one or more features of the cardiac signal comprising at least an R-wave notch feature; and based on one or more of the one or more features meeting one or more corresponding criteria, outputting, by the processing circuitry and for display to a user, an indication to adjust a position of the IMD from the first position to a second position.

[0011] In another example, a non-transitory computer-readable medium stores instructions that when executed cause processing circuitry of a medical device system to: control a pulse generator of the system to generate a pacing pulse when an implantable medical device (IMD) of the system is at a first position in the heart of the patient; control sensing circuity of the system to sense a cardiac signal in response to delivery of the pacing pulse; determine or more features of the cardiac signal comprising at least an R-wave notch feature; and based on one or more of the one or more features meeting one or more corresponding criteria, output for display to a user an indication to adjust a position of the IMD from the first position to a second position.

[0012] This summary is intended to provide an overview of the subject matter described in this disclosure. It is not intended to provide an exclusive or exhaustive explanation of the apparatus and methods described in detail within the accompanying drawings and description below. Further details of one or more examples are set forth in the accompanying drawings and the description below.BRIEF DESCRIPTION OF DRAWINGS

[0013] FIG. 1 illustrates the environment of an example medical device system in conjunction with a patient, in accordance with one or more techniques of this disclosure.

[0014] FIGS. 2A, 2B, 2C, and 2D are conceptual diagrams illustrating example implantable medical devices that operate in accordance with one or more techniques of this disclosure.

[0015] FIG. 3 is a conceptual diagram illustrating an example system for implanting an implantable medical device that operates in accordance with one or more techniques of this disclosure.Atty Ref. No. A0013175W001

[0016] FIG. 4 is a block diagram illustrating an example configuration of an implantable medical device that operates in accordance with one or more techniques of this disclosure.

[0017] FIG. 5 is a block diagram illustrating an example configuration of an external programmer that operates in accordance with one or more techniques of this disclosure.

[0018] FIGS. 6A, 6B, 6C, 6D, and 6E are graphical representations illustrating example notched R-wave morphologies, in accordance with one or more techniques of this disclosure.

[0019] FIG. 7 is a graphical representation illustrating an example cardiac electrogram indicative of a peak deflection index, in accordance with one or more techniques of this disclosure.

[0020] FIG. 8 is a flow chart illustrating an example operation for determining a placement of an implantable medical device based on one or more features of a cardiac signal, in accordance with one or more techniques of this disclosure.

[0021] FIG. 9 is a flow chart illustrating an example operation for determining whether to release an implantable medical device or adjust a position of the implantable medical device, in accordance with one or more techniques of this disclosure.

[0022] Like reference characters refer to like elements throughout the figures and description.DETAILED DESCRIPTION

[0023] A variety of types of implantable and external devices are configured to monitor health based on sensed electrocardiograms (ECGs) and / or cardiac electrograms (EGMs) and, in some cases, other physiological signals, such as an accelerometer signal, a pressure sensor signal, e.g., a blood pressure signal, an impedance signal, and / or a temperature signal. External devices that may be used to non-invasively sense and monitor ECGs and other physiological signals include wearable devices with electrodes configured to contact the skin of a patient, such as patches, watches, rings, necklaces, hearing aids, a wearable cardiac monitor or automated external defibrillator (AED), clothing, car seats, or bed linens. Such external devices may facilitate relatively longer-term monitoring of patient health during normal daily activities.Atty Ref. No. A0013175W001

[0024] Implantable medical device (IMD) systems may also sense and monitor ECGs, cardiac EGMs, and / or other physiological signals and detect health events such as episodes of arrhythmia, cardiac arrest, myocardial infarction, stroke, and seizure. Example IMDs include pacemakers and implantable cardioverter-defibrillators, which may be coupled to intravascular or extravascular leads, as well as pacemakers with housings configured for implantation within the heart, which may be leadless, such as the Micra™ AV Leadless Pacemaker and the Micra™ VR Leadless Pacemaker, available from Medtronic, Inc.

[0025] In some examples, a medical device system including an IMD, e.g., a leadless pacemaker, may provide cardiac pacing therapy to a patient. In some examples, during implantation of the IMD, the system may sense a cardiac signal, e.g., an ECG, a cardiac EGM, and / or another signal produced by a heart of the patient in response to pacing pulses to guide positioning of the IMD. The system may sense the cardiac signal in response to delivery of a pacing pulse from the system to a heart of the patient when the IMD is at a first position within the heart of the patient. The system determines one or more features of the cardiac signal, e.g., the ECG and / or the cardiac EGM, such as one or more of an R-wave notch feature, a peak deflection index (PDI) feature, or a QRS duration feature, a QRS morphology feature, a ventricular activation time featuring, or a pacing impedance feature. Based on one or more of the one or more features meeting one or more corresponding criteria, the system outputs an indication to adjust a position of the IMD from a first position to a second position. Based on the one or more features not meeting the one or more corresponding criteria, the system may output an indication to release the IMD at the first position.

[0026] In some examples, the IMD may be configured for fixation to patient tissue. For example, the IMD may include fixation elements, such as tines or a helical projection for fixating the IMD to patient tissue. In examples in which the IMD comprises a leadless pacemaker, fixating the IMD to patient tissue may comprise fixing the IMD to a target location within the heart, such as a right ventricular (RV) septum. In some examples, the one or more features may not meet the one or more criteria when the position of the IMD is at the target location, e.g., the RV septum. The one or more features may meet the one or more criteria when the position of the IMD is not at the target location, e.g., when the position of the IMD is at an RV free wall of the heart of the patient. In some examples, theAtty Ref. No. A0013175W001system may determine whether the first position is at the target location before determining to release the IMD at the first position or adjust a position of the IMD from the first position to a second position.

[0027] Many procedures involve using fluoroscopic imaging during implantation of IMDs, e.g., leadless pacemakers. However, accurate placement of leadless pacemakers remains challenging. An exact location of the IMD can be difficult for clinicians to identify based on fluoroscopic imaging alone. For example, due to physiological differences in patients, e.g., heart tilts, fluoroscopic imaging alone, the exact location of the IMD may be unclear. By using cardiac signal information, e.g., ECG and / or cardiac EGM information, in addition to or alternatively to fluoroscopic imaging, the techniques of this disclosure may improve an accuracy of leadless pacemaker placement, which may improve patient outcomes. As an example, when a leadless pacemaker is placed at the RV free wall instead of the RV septum, a patient may be more likely to experience pacing-induced cardiomyopathy than when the leadless pacemaker is placed at the RV septum. Therefore, when the leadless pacemaker is placed at the RV septum, the patient may be less likely to experience pacing-induced cardiomyopathy. Although the examples herein are primarily directed to RV septum placement, the techniques of this disclosure may additionally be used to facilitate other placements of the leadless pacemaker, such as atrial placements of the leadless pacemaker.

[0028] Additionally, the techniques of this disclosure may improve an efficiency and confidence associated with performing an implantation procedure. The techniques of this disclosure include determining a position of the IMD based on one or more features of a cardiac signal, e.g., an ECG and / or cardiac EGM, in addition to or alternatively to determine the position of the IMD based on fluoroscopic imaging. In some examples, fluoroscopic imaging may not capture patient-specific physiology, such as a tilt of a heart of a patient within the patient’s chest cavity. By determining the position of the IMD based on the one or more features of the ECG and / or the cardiac EGM, the techniques of this disclosure may facilitate placement of the IMD at a target location. The clinician may also be able to implant the IMD more efficiently using the techniques of this disclosure than when determining the location of the IMD based on fluoroscopic imaging alone since the clinician may be able confirm implant placement more easily using the techniques of this disclosure.Atty Ref. No. A0013175W001

[0029] For the purposes of this disclosure, a cardiac EGM is a cardiac signal measured from within the heart or subcutaneously. An ECG is a cardiac signal measured externally from the patient via a plurality of electrodes placed on the skin of the patient. The ECG may be a 12-lead ECG, a 4-lead ECG, or any other type of ECG. In some examples, the techniques of this disclosure include sensing one or both of the cardiac EGM or the ECG. In some examples, the techniques may include sensing one or more additional signals, such as a mechanical signal, e.g., a heart sounds signal.

[0030] FIG. 1 illustrates the environment of an example medical device system 2 in conjunction with a patient 4, in accordance with one or more techniques of this disclosure. The example techniques may be used with one or more patient sensing devices, e.g., including a device 10, surface electrodes 14, and / or one or more computing devices, e.g., external programmer 12. IMD 10 may be in wireless communication with external programmer 12. Surface electrodes 14 may be in wired or wireless communication with external programmer 12. In some examples, surface electrodes 14 may be in wireless communication with IMD 10. IMD 10 may be a leadless pacemaker. In some examples, external programmer 12 may be configured to, via a plurality of electrodes of surface electrodes 14, sense an ECG, e.g., a 12-lead ECG or a 4-lead ECG.

[0031] In some examples, IMD 10 may configure an interval of stimulation pacing for patient 4 and may provide stimulation pacing to a heart of patient 4. In some examples, IMD 10 may sense a cardiac EGM and / or one or more physiological signals, e.g., an accelerometer signal, determine the intrinsic timing interval, and / or configure the interval of stimulation pacing. System 2 may be configured to determine the location of IMD 10 during an implantation procedure based on the ECG and / or the cardiac EGM.

[0032] IMD 10 includes electrodes and / or other sensors, e.g., an accelerometer, a gyroscope, a temperature sensor, or a pressure sensor, to sense physiological signals of patient 4 and may configure one or more parameters for stimulation pacing for a heart of patient 4 based on the physiological signals.

[0033] In some examples, system 2 includes external programmer 12, which may be a computing device with a display viewable by the user and an interface for providing input to external programmer 12 (i.e., a user input mechanism). External programmer 12 is configured for wireless communication with IMD 10. External programmer 12 retrieves sensed physiological data from IMD 10 that was collected and stored by IMD 10. In someAtty Ref. No. A0013175W001examples, external programmer 12 takes the form of a computing device of the clinician or personal computing device of patient 4. As examples, external programmer 12 may take the form of a tablet or computer of the clinician or a smartphone of patient 4. In some examples, external programmer 12 may be any computing device configured for wireless communication with IMD 10, such as a desktop, laptop, or tablet computer. External programmer 12 may communicate with IMD 10 via near-field communication technologies e.g., inductive coupling, NFC or other communication technologies operable at ranges less than 10-20 cm, and far-field communication technologies, e.g., radiofrequency telemetry according to the Bluetooth® or Bluetooth® Low Energy (BLE) protocols, or other communication technologies operable at ranges greater than near-field communication technologies. When external programmer 12 is configured for use by the clinician, external programmer 12 may be used to transmit instructions to IMD 10. The clinician may also configure and store operational parameters for IMD 10 with the aid of external programmer 12. In some examples, external programmer 12 assists the clinician in the configuration of IMD 10 by providing a system for identifying potentially beneficial operational parameter values.

[0034] Processing circuitry of system 2, e.g., of IMD 10, external programmer 12, and / or one or more other computing devices (not illustrated in FIG. 1) may be configured to perform the example techniques described herein for determining a location of IMD 10 during implantation based on cardiac signal data, e.g., ECG data, cardiac EGM data, and / or other signal data produced by heart 102 in response to pacing pulses, data collected by IMD 10 and / or external programmer 12.

[0035] FIGS. 2A, 2B, 2C, and 2D are conceptual diagrams illustrating example HMDs that operate in accordance with one or more techniques of this disclosure. The IMDs depicted in FIGS. 2A-2D may be similar to or the same as IMD 10. The IMDs depicted in FIGS. 2A-2D may be examples of IMD 10. FIG. 2A is a conceptual diagram illustrating an example of IMD 104 of system 2 implanted in the heart 102 of patient 4, in accordance with one or more aspects of this disclosure.

[0036] IMD 104 is shown implanted in the right ventricle (RV) of the patient’s heart 102 in a target implant region 106, such as within a ventricular septum 108 of heart 102. In some examples, target implant region 106 may be disposed in another position within the heart, such as within a right atrium (RA) of heart 102, e.g., at or near the triangle of Koch.Atty Ref. No. A0013175W001In such examples, target implant region 106 may lie between the bundle of His and the coronary sinus and may be adjacent the tricuspid valve or at another location in the patient’s heart 102. In some examples (not pictured in FIG. 1), target implant region 106 may be located at or around the Bachmann’s bundle of heart 102 and / or a septal wall of the RA of heart 102. In such examples, the variable implantation depth of IMD 104, as described in greater detail below, may increase a range of possible target implant regions 106 for IMD 104. The variable implantation depth of device 104 may also provide for increased adaptability of IMD 104 to the varying anatomies of hearts 102 of different patients.

[0037] In the example of FIG. 2A, a distal end of IMD 104 directed toward the left ventricle (LV) of the patient’s heart 102. Although in the example of FIG. 2A the distal end of IMD 104 is directed toward the LV, the distal end may be directed to other targets.

[0038] IMD 104 includes a distal end 110 and a proximal end 114. Distal end 110 includes a distal electrode 112. Distal electrode 112 may be disposed along an elongated body extending to a distal end. In such examples, distal electrode 112 may be disposed along the elongated body at a position proximal to the distal end of the elongated body. The elongated body may define an elongated barb, a helical shape, or any other elongated shape. Distal electrode 112 may define the entire elongated body and an electrically active region of distal electrode 112 may be disposed at or proximal to the distal end of the elongated body.

[0039] The elongated body and distal electrode 112 extends from distal end 110 and may penetrate into the wall tissue of a chamber of heart 102 (e.g., the RV of heart 102). Distal electrode 112 may penetrate through the wall tissue of a first chamber (e.g., RV) and into wall tissue of a second chamber (e.g., LV). For example, a portion of distal electrode 112 may penetrate through cardiac tissue and be disposed at or around a left bundle branch (LBB) of heart 102.

[0040] Depending on the location of target implantation region 106 and / or a position of target cardiac tissue, the implantation depth for distal electrode 112 may vary. IMD 104 may be coupled to a sheath disposed at or around distal end 110 of IMD 104. The sheath may define one or more tracks or other features configured to interface with corresponding features on IMD 104 (e.g., with distal electrode 112, with one or more other features on an outer surface of IMD 104) to control a distal movement of distal electrode 112 into or outAtty Ref. No. A0013175W001of the tissue at or around target implant region 106. In some examples, the sheath may translate (e.g., via the one or more tracks or other features) a longitudinal movement of IMD 104, thereby providing fine-grain control over the longitudinal movement and / or implantation depth of distal electrode 112. The sheath may provide increased implantation orientations and / or positions for IMD 104 without requiring modification of IMD 104 (e.g., without requiring modification of distal electrode 112), thereby increasing the number of possible use cases for IMD 104.

[0041] The configuration of distal electrode 112 illustrated in FIG. 2A allows IMD 104 to sense cardiac signals and / or deliver cardiac pacing to one or more chambers of heart 102, e.g., the RV, LV, and / or the conduction system of either or both in the illustrated example. In this manner, the configuration of distal electrode 112 may facilitate the delivery of pacing by single IMD 104 implanted within the single chamber, e.g., the RV. While IMD 104 is implanted at target implant region 106 to sense in and / or pace the ventricle(s) in the example shown in FIG. 2A, a device having an electrode configuration in accordance with the examples of this disclosure may be implanted at any of a variety of locations to sense in and / or pace any one, two or more chambers of heart 102. For example, IMD 104 may be implanted at region 106 or another region, and distal electrode 112 may extend into tissue, e.g., myocardial tissue, of the LV or RV septum. Furthermore, a device having an electrode configuration in accordance with the examples of this disclosure may be implanted at any of a variety of locations within a patient for sensing and / or delivery of therapy to other patient tissue, e.g., outside of heart 102.

[0042] While the examples of IMD 104 described herein are described primarily with reference to an electrode assembly including distal electrode 112, other example devices may include a fixation assembly instead of and or in addition to an electrode assembly. In such examples, the fixation assembly may include one or more fixation members including one or more tines, a fixation helix, electrode 112, and / or one or more other fixation mechanisms. In such examples, the fixation assembly may be inserted into and / or secured to IMD 104 via any of the example techniques described below. For example, the fixation assembly may include a fixation member, wherein a proximal end of the fixation assembly is configured to be retained within a recess of an elongated housing of IMD 104 to secure the fixation member to the elongated housing, and wherein when the fixationAtty Ref. No. A0013175W001member is secured to the elongated housing, the fixation member extends distally past the distal end of the elongated housing.

[0043] Additionally, although described primarily in the context of examples in which the medical device that provides cardiac pacing and monitors the cardiac electrogram (EGM) and / or other physiological signals takes the form of a leadless pacemaker, the techniques of this disclosure may be implemented in any one or more medical devices and / or medical device systems, including leaded pacemakers, and in any portion of the heart.

[0044] FIG. 2B is a conceptual diagram illustrating a plan view of a relatively compact IMD 200A including a body 202, a fixation component 204 with a base 206 and one or more tines 208, and an electrode interface assembly (EIA) 210. Body 202 extends along longitudinal axis 212 from a proximal portion 214 to a distal portion 216. Body 202 may be formed from a biocompatible and biostable metal such as titanium. In some examples, body 202 may include a hermetically sealed body. Body 202 may include a nonconductive coating and define a return electrode 218 as an uncoated portion of body 202. IMD 200A may include any suitable dimensions. In some examples, an outer diameter of IMD 200A (e.g., outer diameter of body 202) may be between about 10 French (Fr) and about 30 Fr, such as about 20 Fr.

[0045] As discussed above, fixation component 204 may include base 206 and one or more tines 208. Base 206 may have a proximal end and a distal end aligned along a longitudinal axis, which may or may not be the longitudinal axis of body 202. The proximal end of base 206 may be attached to the distal portion of body 202.

[0046] One or more tines 208 may extend from base 206. For example, as illustrated in FIG. 2B, a penetrator tine 208A may extend from base 206. Penetrator tine 208A is configured to penetrate a tissue to fix IMD 200A to the tissue. Penetrator tine 208A may be configured to hold one or more leadlets in contact with tissue at a target implant site, e.g., target implant site 106.

[0047] In addition to penetrator tine 208A, fixation component 204 may include one or more other tines 208, such as a support tine 208B. Tines 208 may include one or more sections. For example, tines 208 may include an elastically deformable material preset into one or more curved sections and one or more optional substantially straight sections. In some examples, penetrator tine 208A and / or other tines may include one of a plurality ofAtty Ref. No. A0013175W001preset curvatures. In other examples, tines 208 may define a ribbon shape configured to deform along a plane normal to longitudinal axis 212 and resist twisting outside of the plane. In some examples, tines 208 may include two or more curved sections (e.g., knuckles) as described in U.S. Patent No. 11,759,632, entitled “FIXATION COMPONENTS FOR IMPLANTABLE MEDICAL DEVICES,” the entire contents of which are incorporated herein by reference. For example, support tine 208B may be the same or substantially similar to tines described in U.S. Patent Application Publication No.2020 / 0306522.

[0048] Tines 208 may be configured to have a target deflection stiffness and a target deployment stiffness. The target deflection stiffness may include a measure of a resistance to force applied to IMD 200A in a proximal direction when fixation component 204 is engaged with tissue at target site 106. In some examples, the target deflection stiffness may be selected to enable tines 208 to deflect a predetermined amount to enable visualization of tines 208 under fluoroscopy or another imaging modality. In some examples, the target deflection stiffness may be within a range from about 0.2 Newtons (N) to about 0.8 N, such as about 0.3 N to about 0.6 N. The deployment stiffness may include a measure of a force applied by tines 208 as tines 208 move from a deformed configuration to an undeformed configuration upon deployment of fixation component 204 from distal opening 108 of a delivery tool, e.g., of delivery system 300 of FIG. 3, such that the free distal end of tines 208 penetrates pectinate muscle (PM). In some examples, the target deployment stiffness may be within a range from about 0.6 N to about 1.2 N.

[0049] As illustrated in FIG. 2B, IMD 200 A may include EIA 210 having proximal section 209A that defines a proximal end 210A and a distal section 209B that defines a non-incisive distal end 210B. EIA 210 may be configured to control the depth of tissue penetration of penetrator tine 208 A. For example, EIA 210 may be formed such that EIA 210 contacts the tissue at a selected depth of tissue penetration of the penetrator tine. A shape of at least the non-incisive distal end 210B of EIA 210 may be bulbous, polygonal, prismatic, or any other geometry with a face that may be used as a non-incisive distal end to contact tissue. Additionally, the size of EIA 210 may be such that EIA 210 is configured to achieve a selected distance between the incisive distal end 223 of penetrator tine 208 A and non-incisive distal end 210B of EIA 210, thereby controlling the depth of tissue penetration of penetrator tine 208 A. Similarly, EIA 210 may be positioned on IMDAtty Ref. No. A0013175W001200A to achieve the selected distance between the incisive distal section of penetrator tine 208 A and non-incisive distal end 21 OB. In any case, EIA 210 may be configured to control the depth of tissue penetration of penetrator tine 208A by contacting the tissue and resisting further penetration by penetrator tine 208A.

[0050] IMD 200A may contain electronic circuitry, including one or more of sensing circuitry (e.g., for sensing cardiac signals), therapy delivery circuitry (e.g., for generating cardiac pacing pulses), and processing circuitry for controlling the functionality of IMD 200, and may include a first leadlet 220. First leadlet 220 may terminate in a first electrode 222. For example, first leadlet 220 may include a conductor, such as an electrically conductive material, extending through a non-conductive jacket, such as polytetrafluoroethylene (PTFE) coating or polyether ether ketone (PEEK) tube, a portion of the conductor being exposed at first electrode 222. To avoid altering the properties of one or more tines 208 (e.g., penetrator tine 208A) made of a material (e.g., nitinol) that can be affected by electricity, the non-conductive jacket may extend past the one or more tines 208. The electronic circuitry may be configured to generate and deliver an electrical pulse therapy to tissue proximate to first leadlet 220 via first electrode 222, through the tissue to return electrode 218. First leadlet 220 may be spaced apart from distal portion 216 of body 202, for example, being coupled to the sensing and therapy delivery circuitry by the conductor of a hermetic feedthrough assembly (not shown in FIG. 2B).

[0051] IMD may also include a second leadlet 224. Second leadlet 224 may extend from the proximal section of EIA 210 to the distal section of EIA 210. Second leadlet 224 may terminate in a second electrode 226. Second leadlet 224 may be similar to first leadlet 220 in at least some aspects. For example, second leadlet 224 may include a conductor, such as an electrically conductive material, extending through a non-conductive jacket, such as PTFE coating or a PEEK tube, a portion of the conductor being exposed at second electrode 226. First leadlet 220 may function in conjunction with second leadlet 224 for bipolar pacing and sensing, and / or first leadlet 220 and second leadlet 224 may each separately function with return electrode 218 for unipolar pacing and sensing of different selected tissues. In some examples, body 202 may be overlaid with an insulative layer, for example, medical grade polyurethane, parylene, or silicone. In some examples, the insulative layer may define return electrode 218 and / or second electrode 226, for example, by removing a portion of the insulative layer to expose the metallic surface of body 202.Atty Ref. No. A0013175W001Second electrode 226 may be used with first leadlet 220 and / or second leadlet 224 for unipolar pacing and / or sensing.

[0052] In some examples, IMD 200A may include a retrieval structure 228 fixedly attached to proximal end 214 of body 202. Retrieval structure 228 may be configured for temporarily tethering IMD 200A to a delivery catheter or a retrieval catheter, such as delivery tool 106. In some examples, retrieval structure 228 may be configured to couple to tether assemblies, such as those described in U.S. Patent Application Publication No.2020 / 0353242, entitled “TETHER ASSEMBLIES FOR MEDICAL DEVICE DELIVERY SYSTEMS,” the entire contents of which are incorporated herein by reference. FIG. 2C illustrates a different view of IMD 200. In the example of FIG. 2C, tine 208C comprises a support tine similar to tine 208B. In the example of FIG. 2C, tines 208 are in a deployed configuration.

[0053] FIG. 2D illustrates an example leadless IMD 200B. IMD 200B may be substantially similar to or the same as IMD 10 of FIG. 1. IMD 200B may be similar to IMD 200A of FIGS. 2B and 2C. In the example of FIG. 3D, leadless IMD 200A includes tine fixation subassembly 238 and housing subassembly 240. Tine fixation subassembly 238 is configured to anchor leadless IMD 200B to a patient tissue, such as a wall of heart 102, e.g., at target implant 106.

[0054] Housing subassembly 240 includes control electronics 230, which controls the sensing and / or therapy functions of IMD 200B, and battery 232, which powers control electronics 230. As one example, control electronics 230 may include sensing circuitry, a stimulation generator and a telemetry module.

[0055] The housings of control electronics 230 and battery 232 are formed from a biocompatible material, such as a stainless steel or titanium alloy. In some examples, the housings of control electronics 230 and battery 232 may include an insulating coating. Examples of insulating coatings include parylene, urethane, PEEK, or polyimide among others. Housing subassembly 240 further includes anode 234, which may include a low polarizing coating, such as titanium nitride, iridium oxide, ruthenium oxide among others. The entirety of the housings of control electronics 230 and battery 232 are electrically connected to one another, but only anode 234 is uninsulated. In other examples, the entirety of the housing of battery 232 or the entirety of the housing of housing subassembly 240 may function as an anode instead of providing a localized anode such asAtty Ref. No. A0013175W001anode 234. Alternatively, anode 234 may be electrically isolated from the other portions of the housings of control electronics 230 and battery 232.

[0056] Delivery tool interface 236 is located at the proximal end of housing subassembly 240. Delivery tool interface 236 is configured to connect to a delivery device, such as a catheter, used to position IMD 200B during an implantation procedure.

[0057] Tine fixation subassembly 238 includes tines 240 A, 240B, 240C, and 240D (collectively, “tines 240). Tines 240 are deployable from a spring-loaded position in which distal ends of active fixation tines 240 point away from housing subassembly 240 to a hooked position in which active fixation tines 103 bend back towards housing subassembly 240. For example, active fixation tines 240 are shown in the hooked position in FIG. 2D. Active fixation tines 103 are configured to secure IMD 200B to a patient tissue, e.g., a tissue inside the heart or outside the heart, when deployed while the distal ends of active fixation tines 240 are positioned adjacent to the patient tissue. In different examples, active fixation tines 240 may be positioned adjacent to patient tissue such that distal ends of tines 240 penetrate the patient tissue prior to deployment, positioned adjacent to patient tissue such that the distal ends contact but do not penetrate the patient tissue prior to deployment or positioned adjacent to patient tissue such that the distal ends are near to but do not contact or penetrate the patient tissue prior to deployment.

[0058] Tines 240 may be fabricated of a shape memory material, which allows active fixation tines 240 to bend elastically from the hooked position to the spring-loaded position. As an example, the shape memory material may be shape memory alloy such as Nitinol. In one example, portions of fixation subassembly 238, e.g., tines 240, may be manufactured by cutting tines 240 as a unitary component from a hollow tube of Nitinol, bending the cut tube to form the hooked position shape of active fixation tines 240 and heat-treating tines 240 while holding active fixation tines 240 in the hooked position. Sharp edges of fixation subassembly 238 may be rounded off to improve fatigue loading and reduce tearing of patient tissue during deployment and retraction of active fixation tines 240.

[0059] In some examples, all or a portion of fixation subassembly 238, such as active fixation tines 240, may include one or more coatings. For example, fixation subassembly 238 may include a radiopaque coating to provide visibility during fluoroscopy. In one such example, fixation subassembly 238 may include one or more radiopaque markers. AsAtty Ref. No. A0013175W001another example, fixation subassembly 238 may be coated with a tissue growth promoter or a tissue growth inhibitor. A tissue growth promoter may be useful to increase the holding force of active fixation tines 240, whereas a tissue growth inhibitor may be useful to facilitate removal of IMD 200B during an explantation procedure, which may occur many years after the implantation of IMD 200B.

[0060] In some examples, active fixation tines 240 may be used as an electrode for stimulation and / or sensing a physiological condition of a patient and may electrically connect to control electronics 230. During assembly of IMD 200B, once active fixation tines 240 are assembled with fixation subassembly 238, fixation subassembly 238 is interlocked with housing subassembly 240.

[0061] As different patient tissues have different physical and mechanical characteristics, active fixation tines 240 may be specifically designed to perform with patient tissues having specific characteristics. For example, active fixation tines 240 may be designed to provide a selected fixation force, designed to penetrate to a particular depth of a patient tissue, designed to penetrate to a particular layer of patient tissue (as different tissue layers may have different mechanical properties) and / or designed to facilitate removal and redeployment from the patient tissue without tearing the patient tissue, either on deployment or removal. Multiple designs of active fixation tine 240 may be used to optimize fixation for a variety of patient tissues, such as the designs depicted in the example of any of FIGS. 2A-2D.

[0062] FIG. 3 is a conceptual diagram illustrating an example system for implanting an IMD, e.g., IMD 10, IMD 104, IMD 200A, or IMD 200B, that operates in accordance with one or more techniques of this disclosure. FIG. 3 illustrates a partial cut-away section of an example medical device system 300 including a delivery tool 302 and an IMD 200A. For purposes of illustration, the distal end of delivery tool 302 is enlarged relative to handle 318. Additionally, although medical device system 300 is described in reference to fixation component 204 described in reference to FIG. 2A, in other examples, medical device system 300 may include other fixation components, such as helical fixation components or different tine component configurations.

[0063] During use, IMD 200 A may be loaded into delivery tool 302 for deployment to a target implant site (e.g. target implant site 106). Delivery tool 302 may include a handle 318, an elongate outer member 312, and an elongate inner member 308 that extends withinAtty Ref. No. A0013175W001lumen 306 of outer member 312. Inner member 308 may include a distal end 310 configured to engage IMD 200A by abutting proximal end 214 of body 202 (e.g., as shown in the cut-away section). An entirety of IMD 200A may be loaded within tubular sidewall 320 that defines a distal portion of outer member lumen 312, for example, having been loaded therein by pulling IMD 200 A, with body proximal end 214 leading, in through lumen distal opening 304. In some examples, an inner surface 322 of tubular sidewall 320 may engage tines 208 of fixation component 204 as IMD 200A is loaded into lumen 435 to deform tines 208 (per arrow L) and then to hold each tine of tines 208 of the loaded IMD 200A in a deformed configuration, e.g., a spring-loaded configuration.

[0064] Handle 318 may be configured to control movement of delivery tool 302 and / or deployment of IMD 200A. The clinician may position medical device system 300 by advancing delivery tool 302 through vasculature of the patient, for example, from a femoral venous access site and up through the inferior vena cava (IVC) or a radial artery access site. Delivery tool 302 may include articulating features to facilitate the navigation of the distal portion of delivery tool 302. For example, inner member 308 of delivery tool 302 may include a pull wire assembly (not shown) integrated therein and being coupled to another control member 316 of handle 318 that, when moved per arrow A, causes inner member 308 and outer member 312 to bend along distal portions thereof.

[0065] In some examples, a proximal end of outer member 312 may be coupled to a control member 314 of handle 318 such that an entirety of outer member 312 is movable with respect to inner member 308, via control member 314. For example, after positioning medical device system 300 at selected tissue in proximity to a target implant site 106 of FIG. 2, a clinician may retract outer member 312, per arrow W, relative to IMD 200 A and inner member 308, thereby releasing the spring loading fixation component 204 to deploy IMD 200A out through distal opening 304 such that tines 208 engage with the selected tissue to secure IMD 200A at the implant site. Additionally, or alternatively, delivery tool 302 may be configured so that a clinician can advance inner member 308 relative to outer member 312 to push IMD 200A out through distal opening 304 for deployment. A length of outer member 312, between handle 318 and distal opening 304 may be between about 300 cm and about 120 cm.

[0066] Penetrator tine 208A may be configured to penetrate or cut a selected tissue to form a puncture. EIA 210 may be configured to protect first leadlet 220 duringAtty Ref. No. A0013175W001deployment. In some examples, during deployment from delivery catheter 302, penetrator tine 208 A may initially penetrate selected tissue of atrial surface 103 to form a puncture. In some examples, EIA 210 may urge first leadlet 220 toward penetrator tine 208 A, thereby guiding leadlet 220 into the puncture. For example, the shape of the non-incisive distal end of EIA 210 may be configured to urge leadlet 220 toward penetrator tine 208 A by applying a force to leadlet 220 in the direction of penetrator tine 208A during and / or after deployment. By urging leadlet 220 toward penetrator tine 208 A, EIA 210 may reduce undesired displacement of leadlet 220 and / or reduce mechanical damage to leadlet 220 (e.g., as leadlet 220 passes out of delivery catheter 302).

[0067] As fixation component 204 is further deployed, penetrator tine 208A may return from the deployed configuration, for example, as illustrated in FIG. 2C. Upon the penetrator tine 208 reaching the selected depth of tissue penetration, EIA 210 may begin to contact the tissue and resist further tissue penetration. When in the deployed configuration, leadlet 220 may extend in a distal direction between penetrator tine 208A. In this way, leadlet 220 may extend from distal portion 216 of body 202 of IMD 200A to reach a selected target tissue, e.g., target implant region 106. In a similar fashion, leadlet 224 may be urged against patient tissue by EIA 210, and optionally penetrator tine 208 A support tine 208B. In this way, IMD 200A may be configured to penetrate the RV septum to enable pacing and / or sensing via electrodes, e.g., electrodes 222 and / or 226.

[0068] After deployment at target implant region 106, in some examples, a deflection stiffness of tines 208 may enable a clinician to confirm adequate fixation of tines 208 into tissue of a patient. For example, a pull test or tug test may be performed under fluoroscopy to confirm that tines 208 have engaged the tissue to confirm adequacy of implantation of IMD 200A. The pull test or tug test may include the clinician pulling or tugging on the deployed IMD 200A and observing movement of tines 208 to determine if tines 208 are engaged in tissue, e.g., tines 208 that are embedded in tissue deflect or bend as deployed IMD 200A is pulled or tugged. By controlling the deflection stiffness, tines 208 may have an improved flexibility that enables a clinician to more easily confirm tissue engagement.

[0069] In some examples, delivery tool 302 includes one or more electrodes configured to sense a cardiac signal, e.g., a cardiac EGM of patient 4. In some examples, the one or more electrodes are additionally configured to deliver a pacing pulse. DeliveryAtty Ref. No. A0013175W001tool 302 may sense the cardiac signal in response to the delivery of the pacing pulse. The electrodes may be located proximate to distal opening 304 and along tubular sidewall 320.

[0070] During implantation, one or more of delivery tool 302 or IMD 200A may sense a cardiac EGM of patient 4 in response to delivery of a pacing pulse and when IMD 200A is at a first position. In some examples, external programmer 12 additionally or alternatively senses an ECG of patient 4, e.g., by being coupled to patient 4 via surface electrodes 14, which may be disposed on one or more patches, belts, or the like, or via a wired or wireless connection with an ECG device connected to such electrodes. In some examples, delivery tool 302 may be in communication with external programmer 12. Based on one or more features of the cardiac signal, e.g., the cardiac EGM, the ECG, and / or the other signal produced by heart 102 in response to pacing pulses, processing circuitry, e.g., processing circuitry of the IMD, e.g., IMD 200A, IMD 200B, IMD 104, or IMD 10, processing circuitry of external programmer 12, or processing circuitry of another computing device (not depicted in FIG. 1), determines a position of the IMD. The position of the IMD, e.g., IMD 200A may be a position of IMD 200A relative to target implant region 106. If the one or more features of the cardiac EGM and / or the ECG meet one or more corresponding criteria, processing circuitry of IMD 200A and / or external programmer 12 determines to output an indication to adjust the position of IMD 200A from the first position to a second position. If the one or more features do not meet the one or more corresponding criteria, processing circuitry of IMD 200A and / or external programmer 12 may output an indication to deploy IMD 200 A at the first position.

[0071] FIG. 4 is a block diagram illustrating an example configuration of IMD 10 that operates in accordance with one or more techniques of this disclosure. As illustrated in FIG. 4, device IMD 10 include electrodes 418, 420, and 422, which may be configured as described with respect to FIGS. 1-3. IMD 10 may be substantially similar to or the same as any of IMD 104, IMD 200A, or IMD 200B. In some examples, IMD 104, IMD 200A, and IMD 200B may each be example configurations of IMD 10. In some examples, electrodes 418, 420, and 422 may be substantially similar to or the same as electrodes 218, 222, and 226.

[0072] In the example shown in FIG. 4, IMD 10 includes switch circuitry 402, sensing circuitry 404, electrical stimulation circuitry 406, sensor(s) 408, processing circuitry 410, communication circuitry 412, memory 414, and power source 416. The various circuitryAtty Ref. No. A0013175W001may be, or include, programmable or fixed function circuitry configured to perform the functions attributed to respective circuitry. Memory 414 may store computer-readable instructions that, when executed by processing circuitry 410, cause IMD 10 to perform various functions. Memory 414 may be a storage device or other non-transitory medium. The components of IMD 10 illustrated in FIG. 4 may be housed within a housing similar to or the same as any of the housings of IMD 104, IMD 200 A, or IMD 200B as depicted in FIGS. 1-3.

[0073] Electrical stimulation circuitry 406 generates electrical stimulation signals, e.g., cardiac pacing pulses. Switch circuitry 402 is coupled to electrodes 418, 420, and 422, and may include one or more switch arrays, one or more multiplexers, one or more switches (e.g., a switch matrix or other collection of switches), one or more transistors, or other electrical circuitry. Switch circuitry 402 is configured to direct stimulation signals from electrical stimulation circuitry 406 to a selected combination of electrodes 418, 420, and 422, having selected polarities to selectively deliver pacing pulses to the RV septum, the RA, and / or the ventricles of heart 102.

[0074] Each of electrodes 418, 420, and 422 may be coupled to switch circuitry 402 via a corresponding feedthrough assembly. In some examples, each feedthrough assembly may be substantially straight (e.g., along longitudinal axis 212). In some examples, such as when distal end 216 of housing 202 is removable from housing 202 (e.g., when distal end 216 includes a removable header), the feedthrough assemblies may be offset to allow for removal of distal end 216. For example, when a header defining distal end 216 is configured to be removably secured to housing 202, such as via a turn-lock mechanism, the feedthrough assemblies may be offset from longitudinal axis 212 to allow the header to turn relative to housing 202.

[0075] Switch circuitry 402 may also selectively couple sensing circuitry 404 to selected combinations of electrodes 418, 420, and 422 to selectively sense the electrical activity of the ventricles and / or the RA of heart 102, e.g., sense a cardiac EGM signal. Sensing circuitry 404 may include filters, amplifiers, analog-to-digital converters, or other circuitry configured to sense cardiac electrical signals via electrodes 418, 420, and 422. For example, switch circuitry 402 may couple each of first electrode 418 and 420 (in combination with electrode 422) to respective sensing channels provided by sensing circuitry 404 to respectively sense either ventricular or atrial cardiac electrical signals. InAtty Ref. No. A0013175W001some examples, sensing circuitry 404 is configured to detect events, e.g., depolarizations, within the cardiac electrical signals, and provide indications thereof to processing circuitry 410. In this manner, processing circuitry 410 may determine the timing of atrial and ventricular depolarizations, and control the delivery of cardiac pacing, e.g., AV synchronized cardiac pacing, based thereon. Processing circuitry 410 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or any other processing circuitry configured to provide the functions attributed to processing circuitry 410 herein may be embodied as firmware, hardware, software, or any combination thereof.

[0076] In some examples, during an implantation procedure, processing circuitry 410 may be configured to determine whether to deploy IMD 10 at a first position or to adjust the position of IMD 10 from the first position to a second position. For example, processing circuitry 410 may determine one or more features of a cardiac signal, e.g., one or more of a cardiac EGM sensed by IMD 10, an ECG sensed by external programmer 12 via surface electrodes 14, or another signal produced by the heart in response to pacing pulses. The one or more features may include one or more of an R-wave notch feature, a QRS duration feature, or a PDI feature. In some examples, the one or more features may include a QRS morphology feature, a ventricular activation time feature, or a pacing impedance feature. In some examples, the one or more features may vary based on a target implant region of IMD 10. For example, when target implant region 106 is the RV septum of heart 102, the one or more features may include the one or more of the R-wave notch feature, the QRS duration feature, or the PDI feature. When target implant region 106 is at another location, such as with the RA of heart 102 near the triangle of Koch, the one or more features may include the same one or more features and / or different features, such as a pacing impedance feature, a QRS morphology feature, and / or a left ventricular activation time.

[0077] Processing circuitry 410 may compare the one or more features to one or more corresponding criteria. If the one or more features meet the one or more corresponding criteria, processing circuitry 410 may determine to control a user interface of external programmer 12 to output an indication to adjust the position of IMD 10 from the first position to the second position. In some examples, adjusting the position of IMD 10 fromAtty Ref. No. A0013175W001the first position to the second position may include adjusting an angle of IMD 10. If the one or more features do not meet the one or more corresponding criteria, processing circuitry 410 may determine to deploy IMD 10. In some examples, the one or more corresponding criteria may be patient specific. In some examples, the one or more corresponding criteria may vary for each feature of the one or more features based on the target implant region. For example, a criterion corresponding to the QRS duration feature when IMD 10 is configured to be implanted in the RV septum of heart 102 may be different from a criterion corresponding to the QRS duration feature when IMD 10 is configured to be implanted in the RA of heart 102.

[0078] Sensor(s) 408 may include one or more sensing elements that transduce patient physiological activity to an electrical signal to sense values of a respective patient parameter. Sensor(s) 408 may include one or more accelerometers, pressure sensors, impedance sensors, optical sensors, chemical sensors, gyroscopes, temperature sensors, or any other types of sensors. Sensor(s) 408 may output patient parameter values that may be used as feedback to control sensing and delivery of therapy by IMD 10. In examples in which sensor(s) 408 includes an accelerometer, the accelerometer may sense a signal indicative of mechanical activity of heart 102, such as a heart sounds signal.

[0079] Communication circuitry 412 supports wireless communication between IMD 10 and an external programmer 12 (of FIG. 1) or another computing device under the control of processing circuitry 410. Processing circuitry 410 of IMD 10 may receive, as updates to operational parameters from the computing device, and provide collected data, e.g., sensed heart activity or other patient parameters, via communication circuitry 412.

[0080] Power source 416 delivers operating power to various components of IMD 10. Power source 416 may include a rechargeable or non-rechargeable battery and a power generation circuit to produce the operating power. Recharging may be accomplished through proximal inductive interaction between an external charger and an inductive charging coil within IMD 10.

[0081] FIG. 5 is a block diagram illustrating an example configuration of an external programmer that operates in accordance with one or more techniques of this disclosure. In the example shown in FIG. 5, external programmer 12 includes processing circuitry 502, sensing circuitry 504, user interface 506, memory 510, communication circuitry 512, and power source 508. The various circuitry may be, or include, programmable or fixedAtty Ref. No. A0013175W001function circuitry configured to perform the functions attributed to respective circuitry. Memory 510 may store computer-readable instructions that, when executed by processing circuitry 502, cause external programmer 12 to perform various functions. Memory 510 may be a storage device or other non-transitory medium.

[0082] Sensing circuitry 504 may be configured to sense, via one or more electrodes of surface electrodes 14 disposed on skin of patient 4, an ECG of patient 4. Surface electrodes 14 may include electrodes for a 12-lead ECG or another ECG, such as a 4-lead ECG. Sensing circuitry 504 may include filters, amplifiers, analog-to-digital converters, or other circuitry configured to sense cardiac electrical signals via the one or more electrodes. Processing circuitry 502 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), discrete logic circuitry, or any other processing circuitry configured to provide the functions attributed to processing circuitry 410 herein may be embodied as firmware, hardware, software, or any combination thereof.

[0083] In some examples, during an implantation procedure, processing circuitry 502 may be configured to determine whether to deploy an IMD, e.g., IMD 10, IMD 104, IMD 200A, or IMD 200B at a first position or to adjust the position of IMD 10 from the first position to a second position. For example, processing circuitry 502 may determine one or more features of a cardiac signal, e.g., one or more of a cardiac EGM sensed by IMD 10, an ECG sensed by external programmer 12, or another signal produced by heart 102 in response to pacing pulses. Processing circuitry 502 may compare the one or more features to one or more corresponding criteria. If the one or more features meet the one or more corresponding criteria, processing circuitry 502 may determine to control user interface 506 to output an indication to adjust the position of IMD 10 from the first position to the second position. If the one or more features do not meet the one or more corresponding criteria, processing circuitry 502 may determine to deploy IMD 10.

[0084] User interface 506 may include a button or keypad, lights, a speaker for voice commands, a microphone, a turnable knob, a display, such as a liquid crystal (LCD), lightemitting diode (LED), or cathode ray tube (CRT). In some examples the display may be a touch screen. As discussed in this disclosure, processing circuitry 502 may present and receive information relating to a patient condition of patient 4 via user interface 506.During an implantation procedure and when external programmer 12 is a clinicianAtty Ref. No. A0013175W001programmer, user interface 506 may be configured to output indications to the clinician. The indications may include, as examples, text including indications of a position of IMD 10, text indicating whether to adjust the position of IMD 10 or to deploy IMD 10, or one or more graphical representations indicative of the cardiac EGM and / or ECG, fluoroscopic / ultrasound imaging, and / or other related signals. Processing circuitry 502 may also present information to the patient in the form of alerts related to the patient condition and / or a monitoring schedule of the user, e.g., patient 4, the clinician, or a caregiver, via user interface 506.

[0085] Communication circuitry 512 supports wireless communication between external programmer 12 and IMD 10 or another computing device under the control of processing circuitry 502. Processing circuitry 502 of external programmer 12 may receive collected data, e.g., sensed heart signals or other patient parameters, via communication circuitry 512.

[0086] Power source 508 delivers operating power to various components of external programmer 12. Power source 508 may include a rechargeable or non-rechargeable battery and a power generation circuit to produce the operating power.

[0087] FIGS. 6A, 6B, 6C, 6D, and 6E are graphical representations illustrating example notched R-wave morphologies, in accordance with one or more techniques of this disclosure. In the example of FIG. 6A, ECG 601 is a 12-lead ECG including a V5 signal 602A. In some examples, the ECG may be a 4-lead ECG or any other ECG. R-wave 602A includes a notch 604A sensed via a V5 lead of the 12-lead ECG. Notch 604A is an example notched R-wave morphology that may represents an abnormal ventricular activation propagation. In some examples, a notched R-wave may be referred to as a “clumsy” R-wave. During implantation, system 2 may be configured to determine one or more features, including the notched R-wave morphology feature, based on an ECG signal and / or a cardiac EGM sensed in response to delivery of a pacing pulse, e.g., a 5 volt pacing pulse. The pacing pulse may be delivered via one or more electrodes of an IMD, e.g., IMD 10, or may be delivered by one or more electrodes disposed on delivery tool 302. System 2 may determine R-wave notching is present when one or more notches are present in the ECG signal and / or the cardiac EGM signal. In some examples, the notched R-wave may be indicative that a position of IMD 10 should be adjusted. In some examples, when IMD 10 is located at target implant region 106, no R-wave notching isAtty Ref. No. A0013175W001present in the ECG and / or cardiac EGM. FIGS. 6B, 6C, 6D, and 6E are graphical representations illustrating additional notched R-wave morphologies. R-wave 602B of FIG. 6B includes a notch 604B sensed via a V6 lead of the 12-lead ECG. R-wave 602C of FIG. 6C includes a notch 604C sensed via the V6 lead of the 12-lead ECG. R-wave 602D of FIG. 6D includes a notch 604D sensed via the V5 lead of the 12-lead ECG. R-wave 602E of FIG. 6E includes a notch 604E sensed via the V6 lead of the 12-lead ECG. R-wave notches can occur at various times. Each of example notches 604A-604E occur prior to a peak in the respective R-wave signal amplitude. Each of notches 604A-604E have varying amplitudes, durations, and areas under the curve (AUCs). In some examples, processing circuitry of system 2, e.g., processing circuitry 410 of IMD 10 and / or processing circuitry 502 of external programmer, may be configured to determine whether an R-wave includes a notch by determining whether one or more of the amplitude, the duration, or the AUC meets a corresponding criterion. In some examples, processing circuitry 410 and / or processing circuitry 502 may additionally or alternatively be configured to compare each R-wave to one or more template R-waves. As an example, processing circuitry 410 and / or processing circuitry 502 may compare each R-wave to an intrinsic, e.g., unpaced, QRS or R-wave morphology using wavelet comparison. In some examples, processing circuitry 410 and / or processing circuitry 502 may measure segmental amplitudes of the QRS waveform or R-wave to determine whether any notches are present.

[0088] FIG. 7 is a graphical representation illustrating an example cardiac electrogram indicative of a peak deflection index (PDI) that may represent the direction of ventricular activation propagation within ventricles, in accordance with one or more techniques of this disclosure. In the example of FIG. 7, ECG 700 is a 12-lead ECG. The one or more features of the ECG and / or cardiac EGM may include a PDI. In some examples, the PDI may comprise a ratio of a QRS duration 702 and a peak deflection interval 704 of a VI lead corresponding to a pacing pulse delivered by IMD 10 or delivery tool 302 when IMD 10 is positioned at a first position in heart 102 of patient 4. For example, the PDI may be a ratio of a negative peak time interval from an onset of lead VI activation to a corresponding QRS duration. In the example of FIG. 7, the QRS duration 702 is 145 milliseconds. Peak deflection interval is 85 milliseconds, resulting in a PDI of 0.568. In some examples, processing circuitry of system 2, e.g., processing circuitry 410 of IMD 10 and / orAtty Ref. No. A0013175W001processing circuitry 502 of external programmer, may be configured to compare the PDI feature to one or more threshold values. In some examples, the threshold value(s) may vary based on a target implant region for patient 4. For example, if the target implant region is at the RV septum, the threshold value may be 0.475. If the target implant region is in the RA, the threshold value(s) may be different from 0.475. The threshold value may be patient-specific. In some examples, the patient-specific threshold value may be based on a native (e.g., intrinsic or unpaced) PDI feature of patient 4. In some examples, the threshold value may be based on pacing needs of patient 4. Patients who receive more pacing pulses may be more likely to experience pacing-induced cardiomyopathy than patients who receive relatively fewer pacing pulses. As an example, if patient 4 exceeds a percent paced threshold, processing circuitry 410 and / or processing circuitry 502 may determine a relatively lower threshold value.

[0089] If the PDI feature exceeds the threshold value, processing circuitry 410 and / or processing circuitry 502 may determine to output an indication to adjust a position of IMD 10 from a first position to a second position. In some examples, when IMD 10 is located at target implant region 106, the PDI feature is less than the threshold value.

[0090] In addition to or alternatively to the PDI feature, processing circuitry 410 and / or processing circuitry 502 may determine a QRS duration feature. For example, processing circuitry 410 and / or processing circuitry 502 may compare QRS duration 702 to one or more threshold values. In some examples, the one or more threshold values may vary based on a target implant region for patient 4. The one or more threshold values may be patient-specific. In some examples, the one or more patient-specific threshold values may be based on a native QRS duration of patient 4. For example, the one or more threshold values may be a percentage higher or lower than the native QRS duration of patient 4. As another example, the one or more threshold values may be an absolute value, e.g., 10 milliseconds, higher or lower than the native QRS duration of patient 4. Patients who receive more pacing pulses may be more likely to experience pacing-induced cardiomyopathy than patients who receive relatively fewer pacing pulses. As an example, if patient 4 exceeds a percent paced threshold, processing circuitry 410 and / or processing circuitry 502 may determine a relatively lower threshold value.

[0091] In some examples, a first QRS duration threshold value may be 160 milliseconds which is likely associated with pacing-induced cardiomyopathy. A secondAtty Ref. No. A0013175W001QRS duration threshold value may be 150 milliseconds. In some examples, when QRS duration 702 exceeds the first QRS duration threshold value, processing circuitry 410 and / or 502 may determine to output an indication to adjust a position of IMD 10 from the first position to the second position.

[0092] In some examples, when QRS duration 702 exceeds the second QRS duration threshold value but falls below the first QRS duration threshold value, processing circuitry 410 and / or 502 may determine to output an indication to adjust the position of IMD 10 from the first position to the second position in response to a determination that one or more of the notched R-wave feature of the PDI feature meets a corresponding criterion. Additionally, left ventricular activation time can be measured to assess whether the pacing site is close to the ventricular apex or left ventricular septum, which is more relevant to the pacing site of an LBBP leadless pacemaker.

[0093] FIG. 8 is a flow chart illustrating an example operation for determining a placement of an IMD based on one or more features of a cardiac signal, e.g., a cardiac EGM an ECG, and / or or another signal produced by heart 102 in response to pacing pulses, in accordance with one or more techniques of this disclosure. A clinician may, using delivery system 300, position an IMD, e.g., IMD 10, at a first position within a heart of a patient, e.g., heart 102 of patient 4 (802). Positioning IMD 10 at the first position may comprise exposing an electrode of IMD 10 to patient tissue while not yet deploying fixation components, e.g., tines of IMD 10. Positioning IMD 10 at the first position may comprise advancing one or more electrode and / or fixation elements into patient tissue in a manner that can be reversed. In some examples, the clinician may attempt to place IMD 10 at target implant region 106. In some examples, the clinician may position IMD 10 at the first position using fluoroscopic imaging or another imaging modality, such as ultrasound, e.g., echocardiography (ECHO) or computed tomography (CT) imaging. In some examples, the clinician may position IMD 10 at the first position independently.Processing circuitry 410 and / or processing circuitry 502 controls delivery tool 302 or electrical stimulation circuitry 412 to deliver a pacing pulse while IMD 10 is at the first position (804). In some examples, the pacing pulse is a 5 volt pacing pulse. In some examples, the pacing pulse may be less than 5 volts, e.g., 2.5 volts or 3 volts.

[0094] Sensing circuitry, e.g., sensing circuitry 404 of IMD 10 and / or sensing circuitry 504 of external programmer 12, senses one or more cardiac signals in response to theAtty Ref. No. A0013175W001pacing pulse (806). The one or more cardiac signals may include one or more of an ECG, a cardiac EGM, or another signal produced by heart 102 in response to pacing pulses. Processing circuitry 410 and / or processing circuitry 502 determines one or more features of the ECG and / or cardiac EGM (808). The one or more features may include a notched R-wave feature, a PDI feature, and / or a QRS duration feature. In some examples, the one or more features may vary based on a target implant region of HMD 10. For example, when target implant region 106 is the RV septum of heart 102, the one or more features may include the one or more of the R-wave notch feature, the QRS duration feature, or the PDI feature. When target implant region 106 is at another location, such as with the RA of heart 102 near the triangle of Koch, the one or more features may include the same one or more features and / or different features, such as a pacing impedance feature, a QRS morphology feature, and / or a left ventricular activation time.

[0095] Processing circuitry 410 and / or processing circuitry 502 determines whether the one or more features meet one or more corresponding criteria (810). In some examples, the one or more corresponding criteria may be patient specific. In some examples, the one or more corresponding criteria may vary for each feature of the one or more features based on the target implant region. For example, a criterion corresponding to the QRS duration feature when IMD 10 is configured to be implanted in the RV septum of heart 102 may be different from a criterion corresponding to the QRS duration feature when IMD 10 is configured to be implanted in the RA of heart 102.

[0096] In some examples, the notched R-wave feature may meet a corresponding criterion when a notch is present in an R-wave of one or more of a V5 or V6 lead. The notched R-wave feature may not meet the corresponding criterion when no notches are present in the R-wave of the one or more of the V5 or V6 lead. The PDI feature may meet a corresponding criterion when the PDI feature exceeds a threshold value. When the PDI feature is less than the threshold value, the PDI feature may not meet the corresponding criterion. The QRS duration feature may meet a corresponding criterion when the QRS duration is above one or more threshold values. In some examples, processing circuitry 410 and / or processing circuitry 502 may determine one of the one or more features and may, based on a comparison to one or more corresponding criteria, determine whether to determine one or more remaining features. For example, processing circuitry 410 and / or processing circuitry 502 may initially determine the QRS duration feature and compare theAtty Ref. No. A0013175W001QRS duration feature to one or more threshold values. If the QRS duration feature exceeds a first threshold, e.g., 160 milliseconds, processing circuitry 410 and / or processing circuitry 502 may determine to output an indication to adjust the position of IMD 10. If the QRS duration feature is between the first threshold and a second threshold, e.g., 150 milliseconds, or less than the second threshold, processing circuitry 410 and / or processing circuitry 502 may determine one or more of the remaining one or more features.

[0097] Based on the QRS duration feature exceeding the second threshold and / or one or more of the remaining one or more features meeting a corresponding criterion, processing circuitry 410 and / or processing circuitry 502 may determine to output the indication to adjust the position of IMD 10. In some examples, processing circuitry 410 and / or processing circuitry 502 determines each of the QRS duration feature, the PDI feature, and the notched R-wave feature.

[0098] In some examples, if one or more of the features meets the corresponding criteria, processing circuitry 410 and / or processing circuitry 502 determines to output the indication to adjust the position of IMD 10. In some examples, if two or more of the features meet the corresponding criteria, processing circuitry 410 and / or processing circuitry 502 determines to output the indication to adjust the position of IMD 10. In some examples, processing circuitry 410 and / or processing circuitry 502 may apply a weight to each of the features and determine whether to output the indication to adjust the position of IMD 10 based on a resulting overall value.

[0099] In some examples, an extent to which the one or more features meets the corresponding criteria may be indicative of a distance from the first position of IMD 10 to target implant region 106. In some examples, user interface 506 may be configured to output an indication of a distance from the first position of IMD 10 to target implant region 106. In some examples, user interface 506 may output a color coded indication of the location of IMD 10 relative to target implant region 106.

[0100] In response to one or more of the one or more features meeting the one or more corresponding criteria (“YES” of 810), processing circuitry 410 and / or processing circuitry 502 determines to control user interface 506 to output an indication to adjust the position of IMD 10 from the first position to the second position (814). As an example, the one or more of the one or more features may meet the one or more corresponding criteria when the QRS duration feature exceeds a first threshold value, e.g., 160 milliseconds. AsAtty Ref. No. A0013175W001another example, the one or more of the one or more features may meet the one or more corresponding criteria when the notched R-wave feature meets a notched R-wave criterion, e.g., when one or more of the V5 lead or V6 leads includes a notched R wave, and when the QRS duration exceeds a second threshold value less than the first threshold value, e.g., 150 milliseconds. As another example, the one or more of the one or more features may meet the one or more corresponding criteria when the PDI feature exceeds a threshold value, e.g., 0.475, and the QRS duration exceeds the second threshold. As another example, the one or more of the one or more features may meet the one or more corresponding criteria when the notched R-wave feature meets the notched R-wave criterion. As another example, the one or more of the one or more features may meet the one or more corresponding criteria when an amplitude of the R-wave falls below a threshold R-wave amplitude. As another example, the one or more of the one or more features may meet the one or more corresponding criteria when a pacing capture threshold exceeds a pacing capture threshold.

[0100] In some examples, in addition to determining to output the indication to adjust the position of IMD 10 based on the one or more features meeting the one or more corresponding criteria, processing circuitry 410 and / or processing circuitry 502 may determine to output the indication based on imaging, e.g., fluoroscopy, ultrasound, e.g., ECHO, imaging, and / or CT imaging. User interface 506 may display a screen indicative of a location of IMD 10 based on the one or more features and / or the imaging. In some examples, user interface 506 may display an indication of how to adjust the position of IMD 10, e.g., where to place IMD 10.

[0101] Processing circuitry 410 and / or processing circuitry 502 controls delivery tool 302 or electrical stimulation circuitry 412 to deliver a pacing pulse while IMD 10 is at the second position (804). In response to the one or more of the one or more features not meeting the one or more corresponding criteria (“NO” of 810), processing circuitry 410 and / or processing circuitry 502 controls user interface 506 to output an indication to release IMD 10 (812). Releasing IMD 10 may include releasing IMD 10 from distal opening 304 and deploying the fixation components, e.g., tines, of IMD 10.

[0102] FIG. 9 is a flow chart illustrating an example operation for determining whether to release an IMD, e.g., IMD 10, or adjust a position of IMD 10, in accordance with one or more techniques of this disclosure. Processing circuitry 410 and / or processingAtty Ref. No. A0013175W001circuitry 502 controls a pulse generator, e.g., a pulse generator of delivery tool 302 or electrical stimulation circuitry 412 to deliver a pacing pulse while IMD 10 is at the first position (902). In some examples, the pacing pulse is a 5 volt pacing pulse. In some examples, the pacing pulse may be less than 5 volts, such as 3 volts. Processing circuitry 410 and / or processing circuitry 502 controls sensing circuitry, e.g., sensing circuitry 404 of IMD 10 and / or sensing circuitry 504 of external programmer 12, to sense a cardiac signal, e.g., one or more of an ECG, a cardiac EGM, or another signal produced by heart 102 in response to pacing pulses (904). Processing circuitry 410 and / or processing circuitry 502 determines one or more features of the cardiac signal(906). The one or more features may include a notched R-wave feature, a PDI feature, and / or a QRS duration feature. In some examples, the one or more features may vary based on a target implant region of IMD 10. For example, when target implant region 106 is the RV septum of heart 102, the one or more features may include the one or more of the R-wave notch feature, the QRS duration feature, or the PDI feature. When target implant region 106 is at another location, such as with the RA of heart 102 near the triangle of Koch, the one or more features may include the same one or more features and / or different features, such as a pacing impedance feature, a QRS morphology feature, and / or a left ventricular activation time

[0103] Processing circuitry 410 and / or processing circuitry 502 determines whether the one or more features meet one or more corresponding criteria (908). In some examples, the one or more corresponding criteria may be patient specific. In some examples, the one or more corresponding criteria may vary for each feature of the one or more features based on the target implant region. For example, a criterion corresponding to the QRS duration feature when IMD 10 is configured to be implanted in the RV septum of heart 102 may be different from a criterion corresponding to the QRS duration feature when IMD 10 is configured to be implanted in the RA of heart 102.

[0104] In some examples, the notched R-wave feature may meet a corresponding criterion when a notch is present in an R-wave of one or more of a V5 or V6 lead. The notched R-wave feature may not meet the corresponding criterion when no notches are present in the R-wave of the one or more of the V5 or V6 lead. The PDI feature may meet a corresponding criterion when the PDI feature exceeds a threshold value. When the PDI feature is less than the threshold value, the PDI feature may not meet the correspondingAtty Ref. No. A0013175W001criterion. The QRS duration feature may meet a corresponding criterion when the QRS duration is above one or more threshold values.

[0105] In some examples, processing circuitry 410 and / or processing circuitry 502 may determine one of the one or more features and may, based on a comparison to one or more corresponding criteria, determine whether to determine one or more remaining features. For example, processing circuitry 410 and / or processing circuitry 502 may initially determine the QRS duration feature and compare the QRS duration feature to one or more threshold values. If the QRS duration feature exceeds a first threshold, e.g., 160 milliseconds, processing circuitry 410 and / or processing circuitry 502 may determine to output an indication to adjust the position of IMD 10. If the QRS duration feature is between the first threshold and a second threshold, e.g., 150 milliseconds, or less than the second threshold, processing circuitry 410 and / or processing circuitry 502 may determine one or more of the remaining one or more features.

[0106] Based on the QRS duration feature exceeding the second threshold and / or one or more of the remaining one or more features meeting a corresponding criterion, processing circuitry 410 and / or processing circuitry 502 may determine to output the indication to adjust the position of IMD 10. In some examples, processing circuitry 410 and / or processing circuitry 502 determines each of the QRS duration feature, the PDI feature, and the notched R-wave feature. In some examples, if one or more of the features meets the corresponding criteria, processing circuitry 410 and / or processing circuitry 502 determines to output the indication to adjust the position of IMD 10. In some examples, if two or more of the features meet the corresponding criteria, processing circuitry 410 and / or processing circuitry 502 determines to output the indication to adjust the position of IMD 10. In some examples, processing circuitry 410 and / or processing circuitry 502 may apply a weight to each of the features and determine whether to output the indication to adjust the position of IMD 10 based on a resulting overall value.

[0107] In some examples, an extent to which the one or more features meets the corresponding criteria may be indicative of a distance from the first position of IMD 10 to target implant region 106. In some examples, user interface 506 may be configured to output an indication of a distance from the first position of IMD 10 to target implant region 106. In some examples, user interface 506 may output a color coded indication of the location of IMD 10 relative to target implant region 106. User interface 506 mayAtty Ref. No. A0013175W001overlay the color coded indication of the location onto imaging data, e.g., fluoroscopy data.

[0108] In response to one or more of the one or more features meeting the one or more corresponding criteria (“YES” of 908), processing circuitry 410 and / or processing circuitry 502 determines to control user interface 506 to output an indication to adjust the position of IMD 10 from the first position to the second position (912). As an example, the one or more of the one or more features may meet the one or more corresponding criteria when the QRS duration feature exceeds a first threshold value, e.g., 160 milliseconds. As another example, the one or more of the one or more features may meet the one or more corresponding criteria when the notched R-wave feature meets a notched R-wave criterion, e.g., when one or more of the V5 lead or V6 leads includes a notched R wave, and when the QRS duration exceeds a second threshold value less than the first threshold value, e.g., 150 milliseconds. As another example, the one or more of the one or more features may meet the one or more corresponding criteria when the PDI feature exceeds a threshold value, e.g., 0.475, and the QRS duration exceeds the second threshold.Processing circuitry 410 and / or processing circuitry 502 controls the pulse generator to deliver a pacing pulse while IMD 10 is at the second position (914). Processing circuitry 410 and / or processing circuitry 502 controls sensing circuitry 404 and / or sensing circuitry 504 to sense a cardiac signal, e.g., cardiac EGM, an ECG, and / or another signal produced by heart 102 in response to pacing pulses (904).

[0109] In response to the one or more of the one or more features not meeting the one or more corresponding criteria (“NO” of 908), processing circuitry 410 and / or processing circuitry 502 controls user interface 506 to output an indication to release IMD 10 (910). Releasing IMD 10 may include releasing IMD 10 from distal opening 304 and, in some cases, deploying the fixation components, e.g., tines, of IMD 10.

[0110] Example 1. A system comprising: an implantable medical device (IMD) configured to deliver cardiac pacing pulses to a heart of a patient; sensing circuitry configured to sense a cardiac signal; processing circuitry configured to: control a pulse generator to generate a pacing pulse when the IMD is at a first position in the heart of the patient; control the sensing circuity to sense a first cardiac signal in response to delivery of the pacing pulse; determine one or more features of the first cardiac signal comprising at least an R-wave notch feature; and based on one or more of the one or more featuresAtty Ref. No. A0013175W001meeting one or more corresponding criteria, output for display to a user an indication to adjust a position of the IMD from the first position to a second position.

[0111] Example 2. The system of example 1, wherein the one or more features meeting the one or more corresponding criteria comprises the R-wave notch feature being indicative of a presence of one or more notches in one or more R-waves of the patient.

[0112] Example 3. The system of example 1 or 2, wherein the one or more features comprise a QRS duration feature.

[0113] Example 4. The system of example 3, wherein the QRS duration feature meets the one or more corresponding criteria when the QRS duration exceeds one or more QRS threshold values.

[0114] Example 5. The system of any of examples 1-4, wherein the one or more features comprise a peak deflection index feature.

[0115] Example 6. The system of example 5, wherein the one peak deflection index feature meets the one or more corresponding criteria when the peak deflection index feature exceeds a peak deflection index threshold value.

[0116] Example 7. The system of any of example 1-6, wherein the one or more features comprise a plurality of features, and wherein the processing circuitry is configured to: determine a first feature of the plurality of features; based on the first feature meeting a first corresponding criterion of the one or more criteria, determine a second feature of the plurality of features; and based on the second feature meeting a second corresponding criterion of the one or more criteria, output for display to the user the indication to adjust the position of the IMD from the first position to another position.

[0117] Example 8. The system of any of examples 1-7, further comprising a delivery apparatus configured to deliver the IMD to a target position in the heart of the patient, wherein: when the one or more of the one or more features do not meet the one or more criteria, the first position of the IMD is at the target position, and when the one or more of the one or more features meet the one or more criteria, the first position of the IMD is not at the target position.

[0118] Example 9. The system of example 8, wherein when the first position of the IMD is at the target position, processing circuitry outputs an indication to release the IMD.Atty Ref. No. A0013175W001

[0119] Example 10. The system of example 8 or 9, wherein the target position comprises a right ventricular (RV) septum of the heart of the patient.

[0120] Example 11. The system of any of examples 8-10, wherein the delivery apparatus comprises a catheter.

[0121] Example 12. The system of any of examples 1-11, wherein the processing circuitry is further configured to output for display to the user the indication to adjust the position of the IMD from the first position to the second position based on information associated with an imaging modality.

[0122] Example 13. The system of example 12, wherein the imaging modality comprises fluoroscopy or ultrasound.

[0123] Example 14. A method comprising: controlling, by processing circuitry of a medical device system, a pulse generator of the system to generate a pacing pulse when an implantable medical device (IMD) of the system is at a first position in the heart of the patient; controlling, by the processing circuitry, sensing circuity of the system to sense a cardiac signal in response to delivery of the pacing pulse; determining, by the processing circuitry, one or more features of the cardiac signal comprising at least an R-wave notch feature; and based on one or more of the one or more features meeting one or more corresponding criteria, outputting, by the processing circuitry and for display to a user, an indication to adjust a position of the IMD from the first position to a second position.

[0124] Example 15. The method of example 14, wherein the one or more features meeting the one or more corresponding criteria comprises the R-wave notch feature being indicative of a presence of one or more notches in one or more R-waves of the patient.

[0125] Example 16. The method of example 14 or 15, wherein the one or more features comprise a QRS duration feature.

[0126] Example 17. The method of example 16, wherein the QRS duration feature meets the one or more corresponding criteria when the QRS duration exceeds one or more QRS threshold values.

[0127] Example 18. The method of any of examples 14-17, wherein the one or more features comprise a peak deflection index feature.Atty Ref. No. A0013175W001

[0128] Example 19. The method of example 18, wherein the one peak deflection index feature meets the one or more corresponding criteria when the peak deflection index feature exceeds a peak deflection index threshold value.

[0129] Example 20. The method of any of example 14-19, wherein the one or more features comprise a plurality of features, the method further comprising: determining, by the processing circuitry, a first feature of the plurality of features; based on the first feature meeting a first corresponding criterion of the one or more criteria, determining, by the processing circuitry, a second feature of the plurality of features; and based on the second feature meeting a second corresponding criterion of the one or more criteria, outputting, by the processing circuitry and for display to the user, the indication to adjust the position of the IMD from the first position to another position.

[0130] Example 21. The method of any of examples 14-20, wherein the system further comprises a delivery apparatus configured to deliver the IMD to a target position in the heart of the patient, and wherein: when the one or more of the one or more features do not meet the one or more criteria, the first position of the IMD is at the target position, and when the one or more of the one or more features meet the one or more criteria, the first position of the IMD is not at the target position.

[0131] Example 22. The method of example 21, wherein when the first position of the IMD is at the target position, processing circuitry outputs an indication to release the IMD.

[0132] Example 23. The method of example 21 or 22, wherein the target position comprises a right ventricular (RV) septum of the heart of the patient.

[0133] Example 24. The method of any of examples 21-23, wherein the delivery apparatus comprises a catheter.

[0134] Example 25. The method of any of examples 14-24, further comprising: outputting, by the processing circuitry and for display to the user, the indication to adjust the position of the IMD from the first position to the second position based on information associated with an imaging modality.

[0135] Example 26. The method of example 25, wherein the imaging modality comprises fluoroscopy or ultrasound.

[0136] Example 27. A non-transitory computer-readable medium storing instructions that when executed cause processing circuitry of a medical device system to:Atty Ref. No. A0013175W001control a pulse generator of the system to generate a pacing pulse when an implantable medical device (IMD) of the system is at a first position in the heart of the patient; control sensing circuity of the system to sense a cardiac signal in response to delivery of the pacing pulse; determine or more features of the cardiac signal comprising at least an Il-wave notch feature; and based on one or more of the one or more features meeting one or more corresponding criteria, output for display to a user an indication to adjust a position of the IMD from the first position to a second position.

[0137] Various examples have been described. These and other examples are within the scope of the following claims.

Claims

Atty Ref. No. A0013175W001WHAT IS CLAIMED IS:

1. A system comprising:an implantable medical device (IMD) configured to deliver cardiac pacing pulses to a heart of a patient;sensing circuitry configured to sense a cardiac signal;processing circuitry configured to:control a pulse generator to generate a pacing pulse when the IMD is at a first position in the heart of the patient;control the sensing circuity to sense a first cardiac signal in response to delivery of the pacing pulse;determine one or more features of the first cardiac signal comprising at least an R-wave notch feature; andbased on one or more of the one or more features meeting one or more corresponding criteria, output for display to a user an indication to adjust a position of the IMD from the first position to a second position.

2. The system of claim 1, wherein the one or more features meeting the one or more corresponding criteria comprises the R-wave notch feature being indicative of a presence of one or more notches in one or more R-waves of the patient.

3. The system of claim 1 or 2, wherein the one or more features comprise a QRS duration feature.

4. The system of claim 3, wherein the QRS duration feature meets the one or more corresponding criteria when the QRS duration exceeds one or more QRS threshold values.

5. The system of any of claims 1^1, wherein the one or more features comprise a peak deflection index feature.Atty Ref. No. A0013175W0016. The system of claim 5, wherein the one peak deflection index feature meets the one or more corresponding criteria when the peak deflection index feature exceeds a peak deflection index threshold value.

7. The system of any of claim 1-6, wherein the one or more features comprise a plurality of features, and wherein the processing circuitry is configured to:determine a first feature of the plurality of features;based on the first feature meeting a first corresponding criterion of the one or more criteria, determine a second feature of the plurality of features; andbased on the second feature meeting a second corresponding criterion of the one or more criteria, output for display to the user the indication to adjust the position of the IMD from the first position to another position.

8. The system of any of claims 1-7, further comprising a delivery apparatus configured to deliver the IMD to a target position in the heart of the patient, wherein: when the one or more of the one or more features do not meet the one or more criteria, the first position of the IMD is at the target position, andwhen the one or more of the one or more features meet the one or more criteria, the first position of the IMD is not at the target position.

9. The system of claim 8, wherein when the first position of the IMD is at the target position, processing circuitry outputs an indication to release the IMD.

10. The system of claim 8 or 9, wherein the target position comprises a right ventricular (RV) septum of the heart of the patient.

11. The system of any of claims 8-10, wherein the delivery apparatus comprises a catheter.

12. The system of any of claims 1-11, wherein the processing circuitry is further configured to output for display to the user the indication to adjust the position of the IMDAtty Ref. No. A0013175W001from the first position to the second position based on information associated with an imaging modality.

13. The system of claim 12, wherein the imaging modality comprises fluoroscopy or ultrasound.

14. The system of any of claims 1-13, wherein the cardiac signal comprises an electrocardiogram (ECG).

15. The system of any of claims 1-14, wherein the cardiac signal comprises a cardiac electrogram (EGM).